{
    "paper_id": "PMC7168487",
    "metadata": {
        "title": "Chloroquine interferes with dengue\u20102 virus replication in U937 cells",
        "authors": [
            {
                "first": "Kleber",
                "middle": [
                    "Juvenal",
                    "Silva"
                ],
                "last": "Farias",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Paula",
                "middle": [
                    "Renata",
                    "Lima"
                ],
                "last": "Machado",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Renato",
                "middle": [
                    "Ferreira"
                ],
                "last": "de Almeida Junior",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Ana",
                "middle": [
                    "Alice"
                ],
                "last": "de Aquino",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Benedito",
                "middle": [
                    "Ant\u00f4nio",
                    "Lopes"
                ],
                "last": "da Fonseca",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "This study was carried out in strict accordance with the Brazilian Government&apos;s ethical and animal experiments regulations. The procedures for using animals in this research project were in accordance with the ethical principles established by the Brazilian College of Animal Experimentation and the experimental protocol was approved by the Committee on the Ethics of Animal Experiments of the University of Sao Paulo (CETEA/USP, Permit Protocol Number 080/2006).",
            "cite_spans": [],
            "section": "Ethics statement ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Vero cells (an African green monkey kidney cell line) were grown in Leibovitz\u201015 (L\u201015) culture medium (Invitrogen, Grand Island, New York, USA) supplemented with 10% FBS, 1% L\u2010GLUTAMINE 200 mM, 1% penicillin G (100 U/mL), streptomycin (100 \u03bcg/mL) and 10% tryptose phosphate. The Vero cells were maintained at 37 \u00b0C and 5% CO2. C6/36, an Aedes albopictus cell line, was cultured in L\u201015 medium supplemented with 10% FBS, l\u2010glutamine, 10% tryptose phosphate, 1% penicillin G (100 U/mL) and streptomycin (100 \u03bcg/mL) at 28 \u00b0C in the absence of CO2. Suspensions of U937 cells (monocytic lineage) were cultured in RPMI 1640 medium, supplemented with 0.29 g/L L\u2010GLUTAMINE, 2 g/L sodium bicarbonate, 25 mM/L HEPES, 1% penicillin G (100 U/mL), streptomycin (100 \u03bcg/mL) and 10% FBS (Invitrogen) and maintained at 37 \u00b0C and 5% CO2.",
            "cite_spans": [],
            "section": "Cell cultures ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Parental DENV\u20102 New Guinea C strain was recovered from the brains of 1\u2010 to 2\u2010day\u2010old suckling Swiss mice. This virus was passaged several times in C6/36 cells contained in 75 cm2 culture flasks with virus diluted in 1 mL of L\u201015\u20132% FBS. After 1 hr, 14 mL of L\u201015 supplemented with 10% FBS was added and the cells cultured for 7 days. Cells culture supernatants were then harvested and centrifuged at 2000g for 5 min to remove cell debris. The suspensions were kept in ice to prevent further microbial loss. The virus suspensions were adjusted to 20% FBS and then divided into aliquots and stored frozen at \u221270 \u00b0C. Virus stock and cell culture supernatants used in the present study were free of lipopolysaccharides and mycoplasma.",
            "cite_spans": [],
            "section": "Virus stock ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Virus production was titrated by plaque assay using Vero cells. Vero cells were seeded in 12\u2010well (6 \u00d7 105 cells/well) plate in L\u201015 medium with 10% FBS for 48 hr at 37 \u00b0C. The medium was removed and decimal serial dilutions of virus stock or supernatant of U937 cells treated with CLQ prepared in L\u201015 medium with 2% FBS were added (0.1 mL/well) to the cells, which were then incubated for 2 hr at 37 \u00b0C. Subsequently, L\u201015 medium containing 5% FBS and 3% carboxymethyl\u2010cellulose (1 mL/well) (overlay) was added and the plates incubated at 37 \u00b0C for 7 days. The overlay was removed on Day 7 and the cells fixed with a solution of 10% formaldehyde in PBS. After 2 hr at room temperature, the formaldehyde solution was removed and the cells washed twice with PBS and stained (15 min) with a 1% crystal violet solution in 20% ethanol. Plaques of cell lysis were counted and the virus concentration expressed as PFU per mL.",
            "cite_spans": [],
            "section": "Dengue virus titration ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Cytotoxicity induced by CLQ was assayed in U937 cells to determine the ideal concentration for the experiments. Suspension of U937 cells were seeded in 24\u2010well (1 \u00d7 104 cells/well) plates. After an incubation period of approximately 72 hr, the culture medium was replaced with RPMI medium containing 2% FBS and different concentrations of CLQ (Sigma\u2010Aldrich, St Louis, MO, USA). After incubation periods of 1, 6, 12, 24, 48, 72 and 96 hr with the drugs, the U937 cells were removed and their viability confirmed by the Trypan blue exclusion method (Invitrogen).",
            "cite_spans": [],
            "section": "Chloroquine cytotoxic assay ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Indirect immunofluorescence assays were performed to determine the presence of dengue\u20102 viral infection in U937 cells cultures treated with CLQ. To prepare the slides for immunofluorescence, cell suspensions were centrifuged at 1000 rpm for 5 min. The cells were then washed twice with PBS, placed on slides (10 \u00b5L/well), fixed in cold acetone for 10 min and stored at \u221220 \u00b0C. The slides were incubated with DENV\u20102\u2010specific hyperimmune mouse ascitic fluid diluted 1:100 in PBS with 3% FBS at 37 \u00b0C for 30 min in a humidified atmosphere, and then rinsed four times in PBS. The samples were then similarly incubated with a 1:100 dilution of fluorescein isothiocyanate\u2010labeled goat anti\u2010mouse antibodies (Sigma\u2010Aldrich) in Evans blue at 37 \u00b0C for 30 min, rinsed four times in PBS and air dried. After washing, the coverslips were mounted in buffered glycerin, examined at 200\u20131000\u00d7 and photographed using an inverted fluorescence microscope. Fluorescent foci that were located within a 0.7 cm2 area of each well were counted.",
            "cite_spans": [],
            "section": "Indirect immunofluorescence ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Suspensions of U937 cells (1 \u00d7 106 cells/mL) were seeded onto 24\u2010well plates infected with DENV\u20102 (1 \u00d7 106 PFU/mL) at a MOI of 1. At 1 hr post\u2010infection, the inoculums were removed. U937 cells were incubated in the presence of different concentrations of CLQ (0, 0.05, 0.5, 5 and 50 \u03bcg/mL) at the following defined time intervals in different experiments: (i) concomitantly, 1 hr after infection; (ii) concomitantly, 1 hr after infection, and at 24\u2010hr intervals for 7 days; and (iii) concomitantly, 1 hr after infection and at 12\u2010hr intervals for 7 days. Mock controls for DENV\u20102 replication contained no CLQ. Infected cell supernatants were collected at 0, 6, 12, 24, 48, 72, 96, 120, 144 and 168 hr post\u2010infection, cleared by centrifugation, and stored in aliquots at \u221270 \u00b0C until use in real\u2010time PCR and plaque assays. The experiments were carried out in duplicate and the results are shown as the mean values obtained from three individual experiments.",
            "cite_spans": [],
            "section": "Treatment of DENV\u20102 infected cells with CLQ ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Viral RNA was extracted from 140 \u03bcL of each supernatant sample using a QIAamp Viral RNA kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions.",
            "cite_spans": [],
            "section": "Viral RNA extraction ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Total RNA from DENV\u20102 infected or uninfected U937 cells, treated and untreated CLQ (1 hr after infection and at 24\u201324 hr intervals) was extracted after 1, 2, 12, 48 and 72 hr post\u2010infection using the Trizol reagent (Invitrogen) according to the manufacturer's instructions.",
            "cite_spans": [],
            "section": "Total RNA extraction: TRIzol method (guanidinium thiocyanate\u2010phenol\u2010chloroform extraction) ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Real time q\u2010PCR was performed to determine the number of DENV\u20102 RNA copies present in each supernatant, as described previously 13. Briefly, to construct a standard curve, the number of DENV\u20102 particles produced by infected cells was measured as the number of RNA copies quantitated by qRT\u2010PCR in serially diluted infected cell supernatants. Each qRT\u2010PCR contained 12.5 \u03bcL of Sybr Green Master Mix reagent (Applied Biosystems, Foster, CA, USA), 0.5 \u03bcL of RNase inhibitor, 0.13 \u03bcL of MultiScribe (50 U/\u03bcL; Life Technologies, Carlsbad, CA, USA), 0.5 \u03bcL of primers (20 nM) DV2U (5\u2032\u2010AAGGTGAGATGAAGCTGTAGTCTC\u20103\u2032), and DVL1 (5\u2032\u2010CATTCCATTTTCTGGCGTTCT\u20103\u2032) 14 specifically designed to anneal to the DENV\u20102 3\u2032\u2010untranslated region (3\u2032\u2010UTR), 5.87 \u03bcL of diethylpyrocarbonate water and 5 \u03bcL of RNA to a final volume of 25 \u03bcL. The amplification protocol consisted of the following steps: 48 \u00b0C for 30 min, 95 \u00b0C for 10 min, followed by 40 cycles at 95 \u00b0C for 15 sec, and finally 60 \u00b0C for 1 min. The same protocol was used to quantify the DENV\u20102 RNA copies present in the supernatants of CLQ\u2010treated and untreated U937 cells infected with DENV\u20102, collected at defined post\u2010infection intervals, as described above.",
            "cite_spans": [],
            "section": "qRT\u2010PCR assay ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Relative quantification of cytokines (IFN\u2010\u03b1, IFN\u2010\u03b2, IFN\u2010\u03b3, TNF\u2010\u03b1, IL\u20106, IL\u201012 and IL\u201010) in relation to the transcripts of \u03b2\u2010actin gene (endogenous control) was performed using PCR reactions in real time using a QuantiTect SYBR Green PCR kit (Qiagen). The reactions were performed in a final volume of 25 \u00b5L containing 1 \u00b5L of cDNA, 12.5 \u00b5L of 2\u00d7 QuantiTect SYBR Green PCR Master Mix (HotStarTaq DNA polymerase, QuantiTect SYBR Green PCR buffer, SYBR Green I and ROX fluorophore used as a passive reference for normalization levels of fluorescence) and 0.5 \u00b5L of oligonucleotide sense and antisense (20 nm) (Table 1) under the following conditions: 95 \u00b0C for 15 min, followed by 40 cycles of 94 \u00b0C for 15 sec, 60 \u00b0C for 30 sec, and 72 \u00b0C for 30 sec.",
            "cite_spans": [],
            "section": "qRT\u2010PCR assay ::: MATERIALS AND METHODS",
            "ref_spans": [
                {
                    "start": 614,
                    "end": 615,
                    "mention": "1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "The extracted RNA was converted into cDNA through reactions with reverse transcriptase enzyme M\u2010MLV (Invitrogen) according to the manufacturer&apos;s protocol. To prepare the cDNA, concentrations of 400 \u03b7g of total RNA were used for all samples.",
            "cite_spans": [],
            "section": "Complementary DNA synthesis ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Statistical analysis was used to assess differences between viral yield at time\u2010defined intervals from infected cells in contact with CLQ and control cells (without the drug). Data were entered into the GraphPad Prism software, version 6.0 and submitted to one\u2010way ANOVA (nonparametric test) analysis followed by the Bonferroni test. Cytokine mRNA quantification by real\u2010time PCR was tested using Student's t\u2010test. for all analyses, values of P < 0.05 were considered statistically significant.",
            "cite_spans": [],
            "section": "Statistical analysis ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Chloroquine was highly cytotoxic to U937 cells when they were treated with a concentration \u2265500 \u03bcg/mL, whereas no significant cytotoxicity was observed when the cells were treated with a concentration \u226450 \u03bcg/mL (Fig. 1). Based on these data, CLQ was used in concentrations \u226450 \u03bcg/mL in these experiments.",
            "cite_spans": [],
            "section": "Cytotoxicity of CLQ in U937 cells ::: RESULTS",
            "ref_spans": [
                {
                    "start": 217,
                    "end": 218,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "To determine whether CLQ inhibits DENV\u20102 replication, suspensions of U937 cells were infected with DENV\u20102 and incubated with 2% FBS RPMI medium containing different concentrations of the drug; then virus production was quantified by qRT\u2010PCR and plaque assay. Results of qRT\u2010PCR showed that CLQ inhibited DENV\u20102 replication in U937 cells in a dose\u2010dependent manner (Fig. 2a). Viral replication in U937 cells was significantly less after addition of  \u2265 5 \u03bcg/mL of CLQ 1 hr after infection than in untreated cells; this inhibition was maintained up to 24 hr after infection (Fig. 2). The same results were obtained when virus production was assessed by plaque assay, the results showing an excellent correlation with those of qRT\u2010PCR (Fig. 2b).",
            "cite_spans": [],
            "section": "Effect of CLQ on DENV\u20102 replication as assessed by qRT\u2010PCR ::: RESULTS",
            "ref_spans": [
                {
                    "start": 370,
                    "end": 371,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 577,
                    "end": 578,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 737,
                    "end": 738,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Because the duration of viral inhibition effect induced by CLQ may have been related to the timing of drug administration, the antiviral effect of CLQ was further analyzed in U937 cells treated with the drug 1 hr after infection and at 24\u2010 and 12\u2010hr intervals post\u2010infection. qRT\u2010PCR showed that treated cells produced significantly less virus than untreated cells up to the 7th day after infection (Figs 3a and 4). Again, assessment by plaque assay was in agreement with that by qRT\u2010PCR (Fig. 3b).",
            "cite_spans": [],
            "section": "Effect of CLQ on DENV\u20102 replication as assessed by qRT\u2010PCR ::: RESULTS",
            "ref_spans": [
                {
                    "start": 412,
                    "end": 413,
                    "mention": "4",
                    "ref_id": "FIGREF3"
                },
                {
                    "start": 494,
                    "end": 495,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "U937 cells infected or uninfected with dengue\u20102 virus in the presence and absence of CLQ added 1 hr after infection and thereafter at 24 hr intervals yielded significantly less virus than untreated cells up to the sixth day after infection (Fig. 5).",
            "cite_spans": [],
            "section": "Effect of CLQ on DENV\u20102 replication assessed by IFA ::: RESULTS",
            "ref_spans": [
                {
                    "start": 246,
                    "end": 247,
                    "mention": "5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "To determine whether CLQ interfered with IFN\u2010\u03b1, IFN\u2010\u03b2, IFN\u2010\u03b3, TNF\u2010\u03b1, IL\u20106, IL\u201012 and IL\u201010 release pretranslation, the effect of this drug on cytokines\u2019 mRNA expression was investigated by real\u2010time PCR in U937 cells infected or uninfected with DENV\u20102 and treated and untreated with CLQ (Fig. 6). In infected U937 cells, treatment with CLQ downregulated expression of the proinflammatory cytokines, IFN\u2010\u03b2, IFN\u2010\u03b3, TNF\u2010\u03b1, IL\u20106 and IL\u201012 compared with the positive control (Fig. 6b\u2013f). In the case of IFN\u2010\u03b1, expression was inhibited at hour 72 post\u2010infection (Fig. 6a). There was no statistically significant difference in expression of the anti\u2010inflammatory cytokine IL\u201010 compared with the positive control (Fig. 6g).",
            "cite_spans": [],
            "section": "Analysis of cytokines by real\u2010time PCR ::: RESULTS",
            "ref_spans": [
                {
                    "start": 293,
                    "end": 294,
                    "mention": "6",
                    "ref_id": "FIGREF5"
                },
                {
                    "start": 476,
                    "end": 477,
                    "mention": "6",
                    "ref_id": "FIGREF5"
                },
                {
                    "start": 562,
                    "end": 563,
                    "mention": "6",
                    "ref_id": "FIGREF5"
                },
                {
                    "start": 712,
                    "end": 713,
                    "mention": "6",
                    "ref_id": "FIGREF5"
                }
            ]
        },
        {
            "text": "In addition to its antimalarial effect, CLQ may interfere with the replication cycle of many viruses by interacting with viral entry mediated by endosomes or in the late stages of replication of enveloped viruses 15.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "Chloroquine, an 9\u2010aminoquinoline, was first synthesized in Germany by Bayer in 1934 and emerged during the first half of the 20th century as an effective substitute for quinine, the previous drug of choice against malaria 16, 17. It has multiple mechanisms of action; these differ according to the pathogen. It is a weak base which increases the pH of acidic vesicles and is concentrated in acidic organelles such as endosomes, lysosomes, vesicles and the Golgi by a mechanism involving a proton pump which requires energy, increasing the pH.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "During the last decades, two major mechanisms of action of CLQ have been well described: alkalization of acidic vesicles, thereby interfering with endosome\u2010mediated viral entry, and alteration of post\u2010translational modifications of proteins newly synthesized in cells infected by virus 18.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "We demonstrate here the antiviral effect of CLQ on U937 cells infected with DENV\u20102. Our findings are in agreement with those reported by Farias et al., who showed that when Vero cells infected with DENV\u20102 are treated with CLQ at 1 hr post\u2010infection and at different time intervals (24/12 hr), viral replication decreases in a dose dependent manner 19.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "\nIn vitro studies have demonstrated that CLQ has a strong antiviral effect on viruses such such as hepatitis B virus, herpes simplex virus type 1, influenza virus, human immunodeficiency virus, severe acute respiratory syndrome (coronavirus) and Epstein\u2010Barr virus 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30. Our in vitro study has demonstrated the therapeutic action of CLQ after exposure to the dengue\u20102 virus (1 hr after infection). Recent studies have shown that CLQ treatment inhibits DENV\u20102\u2010induced mTRAIL relocalization and IFN\u2010\u03b1 production by plasmacytoid dendritic cells 31. One study showed that patients with dengue treated with CLQ have an improved quality of life and are able to resume their daily activities 32.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "Tricou et al. evaluated the effect of CLQ in adult patients with dengue and found that treatment with CLQ had no effect on viremia or NS1 antigenemia 33. Their study had some limitations. They measured viremia by quantitative RT\u2010PCR as a surrogate and well\u2010characterized marker of infection, though they recognized this is not the same as a quantitative biological assay of infectious virus 33. In our in vitro study, we measured viral yield by quantitative RT\u2010PCR and plaque assay.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "Regarding the amount of cytokines in cell culture (U937) as assessed by real\u2010time PCR, we found that infected U937 cells treated with CLQ contained significantly less IFN\u2010\u03b2, IFN\u2010\u03b3, TNF\u2010\u03b1, IL\u20106, and IL\u201012 than the positive control (Fig. 6b\u2013f). CLQ reduced IFN\u2010\u03b1 production 72 hr post\u2010infection (6a). The drug reduced production of proinflammatory cytokines by interfering with mRNA synthesis of IL\u201012, IFN\u2010\u03b3, IL\u20106, TNF\u2010\u03b1, IFN\u2010\u03b2 and IFN\u2010\u03b1.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 236,
                    "end": 237,
                    "mention": "6",
                    "ref_id": "FIGREF5"
                }
            ]
        },
        {
            "text": "Van den borne et al. showed that CLQ decreases production of proinflammatory cytokines such as INF\u2010\u03b3, TNF\u2010\u03b1 and IL\u20106 in peripheral blood mononuclear cells stimulated with LPS 34. Chloroquine inhibits the release of TNF\u2010\u03b1 in macrophages by inhibiting synthesis of TNF\u2010\u03b1 mRNA 35, 36. Jang et al. showed that CLQ interferes with production of the cytokines TNF\u2010\u03b1, IL\u20101\u03b2 and IL\u20106 from monocytes/macrophages stimulated with LPS 37. Chloroquine reportedly decreases expression of TNF\u2010\u03b1 receptors on the surfaces of human histiocytic U937 cells by delaying its transport to cell surface 38. Gandini et al. showed that CLQ treatment completely blocks IFN\u2010\u03b1 secretion by plasmacytoid dendritic cells 31. Silva et al. showed that CLQ\u2010mediated blocking of this process partially inhibits West Nile virus\u2010induced IFN\u2010\u03b1 production by plasmacytoid dendritic cells cultures 39.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "Our results corroborate those of such studies, demonstrating that CLQ interferes with expression of proinflammatory cytokines.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "We postulated that the reduction in proinflammatory cytokines in infected cells treated with CLQ could be due to the drug's anti\u2010inflammatory effects, particularly because CLQ is a TNF\u2010\u03b1 inhibitor 40. Another possible mechanism of the effect of CLQ in cells infected with dengue virus could be via its antiviral action, which decreases the viral load and thus the degree of immune system activation.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "In conclusion, the therapeutic use as CLQ, which is considered a safe and effective drug and is used to treat many diseases, including malaria, could be expanded because we have shown in this study that the drug has a significant antiviral effect on the replication of DENV\u20102 in cells culture. Chloroquine is a well known immunomodulatory agent 15. These data indicate that CLQ inhibits IFN\u2010\u03b1, IFN\u2010\u03b2, IFN\u2010\u03b3, TNF\u2010\u03b1, IL\u20106 and IL\u201012 genes expression in U937cells infected with DENV\u20102 and treated with CLQ.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "All authors declare that they have no conflict of interests.",
            "cite_spans": [],
            "section": "DISCLOSURE",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Primers for quantitative real\u2010time PCR\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: \nThe effect of CLQ on the cytotoxicity in U937 cells.\n Concentrations equal or higher than 500 \u03bcg/mL (CLQ) were highly cytotoxic to U937 cells, while concentrations equal or lower than 50 \u03bcg/mL (CLQ) did not induce significant cytotoxicity.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: \nAction of CLQ on DENV\u20102 replication in U937 cells.\n (a) The viral RNA present in the culture supernatants of U937cells infected with DENV\u20102, treated and untreated CLQ post\u2010infection, was extracted and analyzed by qRT\u2010PCR. (b) Culture supernatants of U937cells infected with DENV\u20102, treated and untreated CLQ post\u2010infection, were analyzed by plaque assay. The results represent the average values of the viral RNA copy number (P  < 0.001).",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: \nAction of CLQ added at 24\u2010hr intervals on DENV\u20102 replication in U937 cells.\n (a) The viral RNA present in the culture supernatants of U937 cells infected with DENV\u20102, treated and untreated CLQ (every 24 hr post\u2010infection), was extracted and analyzed by qRT\u2010PCR. (b) Culture supernatants of U937 cells infected with DENV\u20102, treated and untreated CLQ (every 24 hr post\u2010infection), was analyzed by plaque assay. The results represent the average values of the viral RNA copy number (P  < 0.05).",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Figure 4: \nAction of CLQ added at 12\u2010hr intervals on DENV\u20102 replication in U937 cells.\n The viral RNA present in the culture supernatants of U937 cells infected with DENV\u20102, treated and untreated CLQ (every 12 hr post\u2010infection), was extracted and analyzed by qRT\u2010PCR. The results represent the average values of the viral RNA copy number (P  < 0.05).",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Figure 5: \nIndirect immunofluorescence assay.\n Detection of DENV\u20102 virus in U937 cells infected or uninfected, treated and untreated CLQ (every 24 hr post\u2010infection). (Original magnification 200\u20131,000\u00d7).",
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Figure 6: \nRelative quantification of cytokines by real\u2010time PCR in U937 cells infected or not with DENV\u20102 in the presence or absence of CLQ added at 24\u2010hr intervals.\n IFN\u2010\u03b1 (a), IFN\u2010\u03b2 (b), IFN\u2010\u03b3 (c), TNF\u2010\u03b1 (d), IL\u20106 (e), IL\u201012 (f), and IL\u201010 (g) mRNA expression in DENV\u20102 infected or uninfected U937 cells, treated and untreated CLQ were analyzed by quantitative RT\u2010PCR, and normalized to mouse beta actin gene. Values were submitted to t test in which *P < 0.05 vs. U937 cells infected with DENV\u20102s.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [],
            "year": 1985,
            "venue": "International Catalog of Arboviruses Including Certain Other Viruses of Vertebrates",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Dengue: An escalating problem",
            "authors": [],
            "year": 2002,
            "venue": "Br Med J",
            "volume": "324",
            "issn": "",
            "pages": "1563-6",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Dengue and dengue haemorrhagic fever",
            "authors": [],
            "year": 1998,
            "venue": "Lancet",
            "volume": "353",
            "issn": "",
            "pages": "971-7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "",
            "authors": [],
            "year": 2001,
            "venue": "Fields Virology",
            "volume": "33",
            "issn": "",
            "pages": "1043-1126",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Dengue virus envelope glycoprotein structure: New insight into its interactions during viral entry",
            "authors": [],
            "year": 2003,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "100",
            "issn": "",
            "pages": "6899-901",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Flavivirus genome organization, expression, and replication",
            "authors": [],
            "year": 1990,
            "venue": "Annu Rev Microbiol",
            "volume": "44",
            "issn": "",
            "pages": "649-88",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "",
            "authors": [],
            "year": 1996,
            "venue": "Fields Virology",
            "volume": "",
            "issn": "",
            "pages": "931-959",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "DC\u2010SIGN (CD209) mediates dengue virus infection of human dendritic cells",
            "authors": [],
            "year": 2003,
            "venue": "J Exp Med",
            "volume": "197",
            "issn": "",
            "pages": "823-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Dendritic cell\u2010specific intercellular adhesion molecule 3\u2010grabbing non\u2010integrin (DCSIGN)\u2010mediated enhancement of dengue virus infection is independent of DC\u2010SIGN internalization signals",
            "authors": [],
            "year": 2005,
            "venue": "J Biol Chem",
            "volume": "280",
            "issn": "",
            "pages": "23698-708",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "The mannose receptor mediates dengue virus infection of macrophages",
            "authors": [],
            "year": 2008,
            "venue": "PLoS Pathog",
            "volume": "4",
            "issn": "",
            "pages": "1-11",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line",
            "authors": [],
            "year": 1998,
            "venue": "J Infect Dis",
            "volume": "178",
            "issn": "",
            "pages": "1270-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Lysosomes revisited",
            "authors": [],
            "year": 1983,
            "venue": "Eur J Biochem",
            "volume": "137",
            "issn": "",
            "pages": "391-7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "SYBR green and TaqMan real\u2010time PCR assays are equivalent for the diagnosis of dengue virus type 3 infections",
            "authors": [],
            "year": 2006,
            "venue": "J Med Virol",
            "volume": "78",
            "issn": "",
            "pages": "760-3",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Development of a fluorogenic RT\u2010PCR system for quantitative identification of dengue virus serotypes 1\u20104 using conserved and serotype\u2010specific 3(noncoding sequences",
            "authors": [],
            "year": 2001,
            "venue": "J Virol Methods",
            "volume": "95",
            "issn": "",
            "pages": "19-32",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Effects of chloroquine on viral infections: An old drug against today's diseases?",
            "authors": [],
            "year": 2003,
            "venue": "Lancet Infect Dis",
            "volume": "3",
            "issn": "",
            "pages": "722-7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "",
            "authors": [],
            "year": 1981,
            "venue": "Chemotherapy of Malaria",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Chloroquine\u2010resistant malaria",
            "authors": [],
            "year": 2001,
            "venue": "J Infect Dis",
            "volume": "184",
            "issn": "",
            "pages": "770-6",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century",
            "authors": [],
            "year": 2007,
            "venue": "Int J Antimicrob Agents",
            "volume": "30",
            "issn": "",
            "pages": "297-308",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells",
            "authors": [],
            "year": 2013,
            "venue": "Sci World J",
            "volume": "2013",
            "issn": "",
            "pages": "1-5",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled\u2010DNA active compounds",
            "authors": [],
            "year": 1990,
            "venue": "J Med Virol",
            "volume": "31",
            "issn": "",
            "pages": "90-7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Inhibition of duck hepatitis B virus infection by lysosomotropic agents",
            "authors": [],
            "year": 1991,
            "venue": "Virology",
            "volume": "183",
            "issn": "",
            "pages": "415-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Inhibition of multiplication of herpes simplex virus type 1 by ammonium chloride and chloroquine",
            "authors": [],
            "year": 1984,
            "venue": "Virology",
            "volume": "138",
            "issn": "",
            "pages": "332-5",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "\nIn vitro inhibition of human influenza A virus replication by chloroquine",
            "authors": [],
            "year": 2006,
            "venue": "Virol J",
            "volume": "3",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes",
            "authors": [],
            "year": 1993,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "9",
            "issn": "",
            "pages": "91-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Chloroquine inhibits HIV\u20101 replication in human peripheral blood lymphocytes",
            "authors": [],
            "year": 1998,
            "venue": "Immunol Lett",
            "volume": "64",
            "issn": "",
            "pages": "45-47",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Anti\u2010HIV effects of chloroquine: Inhibition of viral particle glycosylation and synergism with protease inhibitors",
            "authors": [],
            "year": 2004,
            "venue": "J Acquir Immune Defic Syndr",
            "volume": "35",
            "issn": "",
            "pages": "223-32",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "\nIn vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine",
            "authors": [],
            "year": 2004,
            "venue": "Biochem Biophys Res Commun",
            "volume": "323",
            "issn": "",
            "pages": "264-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Chloroquine is a potent inhibitor of SARS coronavirus infection and spread",
            "authors": [],
            "year": 2005,
            "venue": "Virol J",
            "volume": "2",
            "issn": "",
            "pages": "1-10",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "Potential antivirals and antiviral strategies against SARS coronavirus infections",
            "authors": [],
            "year": 2006,
            "venue": "Expert Rev Anti Infect Ther",
            "volume": "4",
            "issn": "",
            "pages": "291-302",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "Epstein\u2010Barr virus enters B cells and epithelial cells by different routes",
            "authors": [],
            "year": 1992,
            "venue": "J Virol",
            "volume": "66",
            "issn": "",
            "pages": "3409-14",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Dengue virus activates membrane TRAIL relocalization and IFN\u2010\u03b1 production by human plasmacytoid dendritic cells in vitro and in vivo",
            "authors": [],
            "year": 2013,
            "venue": "PLoS Negl Trop Dis",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Chloroquine use improves dengue\u2010related symptoms. Mem Inst Oswaldo Cruz",
            "authors": [],
            "year": 2013,
            "venue": "Mem Inst Oswaldo Cruz, Rio de Janeiro",
            "volume": "108",
            "issn": "5",
            "pages": "596-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults",
            "authors": [],
            "year": 2010,
            "venue": "PLoS Negl Trop Dis",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Chloroquine and hydroxychloroquine equally affect tumor necrosis factor\u2010alpha, interleukin 6, and interferon\u2010gamma production by peripheral blood mononuclear cells",
            "authors": [],
            "year": 1997,
            "venue": "J Rheumatol",
            "volume": "24",
            "issn": "",
            "pages": "55-60",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Chloroquine interferes with lipopolysaccharide\u2010induced TNF\u2010alpha gene expression by a nonlysosomotropic mechanism",
            "authors": [],
            "year": 2000,
            "venue": "J Immunol",
            "volume": "165",
            "issn": "",
            "pages": "1534-40",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Inhibition of mitogen\u2010activated protein kinase signaling by chloroquine",
            "authors": [],
            "year": 2002,
            "venue": "J Immunol",
            "volume": "168",
            "issn": "",
            "pages": "5303-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Chloroquine inhibits production of TNF\u2010alpha, IL\u20101beta and IL\u20106 from lipopolysaccharide\u2010stimulated human monocytes/ macrophages by different modes",
            "authors": [],
            "year": 2006,
            "venue": "Rheumatology (Oxford)",
            "volume": "45",
            "issn": "",
            "pages": "703-10",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Chloroquine decreases cell\u2010 surface expression of tumour necrosis factor receptors in human histiocytic U\u2010937 cells",
            "authors": [],
            "year": 2002,
            "venue": "Immunology",
            "volume": "105",
            "issn": "",
            "pages": "83-91",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Differential activation of human monocyte\u2010derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells",
            "authors": [],
            "year": 2007,
            "venue": "J Virol",
            "volume": "81",
            "issn": "",
            "pages": "13640-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide\u2010stimulated RAW 264. 7 macrophages",
            "authors": [],
            "year": 1997,
            "venue": "J Immunol",
            "volume": "158",
            "issn": "",
            "pages": "4901-7",
            "other_ids": {
                "DOI": []
            }
        }
    }
}